tiprankstipranks
Trending News
More News >
OSE Immunotherapeutics (DE:6OP)
:6OP
Germany Market

OSE Immunotherapeutics SA (6OP) Income Statement

Compare
1 Followers

OSE Immunotherapeutics SA Income Statement

Last quarter (Q4 2024), OSE Immunotherapeutics SA's total revenue was €831.00K, a decrease of -63.15% from the same quarter last year. In Q4, OSE Immunotherapeutics SA's net income was €-19.73M. See OSE Immunotherapeutics SA’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
€ 69.88M€ 2.23M€ 18.30M€ 26.31M€ 10.42M
Gross Profit
€ 0.00€ 2.23M€ 18.30M€ 26.31M€ 10.42M
Operating Expenses
€ 33.45M€ 25.21M€ 38.78M€ 45.67M€ 29.41M
Depreciation and Amortization
€ 6.26M€ 3.52M€ 3.56M€ 2.66M€ 730.00K
EBITDA
€ 46.31M€ -17.50M€ -13.11M€ -13.72M€ -18.24M
Operating Income
€ 30.17M€ -22.99M€ -18.48M€ -16.63M€ -18.99M
Other Income/Expenses
€ -3.90M€ -235.00K€ 454.00K€ -588.00K€ -257.00K
Pretax Income
€ 39.83M€ -23.22M€ -23.45M€ -21.56M€ -24.37M
Net Income
€ 37.45M€ -23.00M€ -17.76M€ -16.85M€ -16.55M
Per Share Metrics
Basic EPS
€ 1.72€ -1.18€ -0.96€ -0.93€ -1.06
Diluted EPS
€ 1.48€ -1.18€ -0.96€ -0.93€ -1.06
Weighted Average Shares Outstanding
21.81M 19.56M 18.46M 18.16M 15.56M
Weighted Average Shares Outstanding (Diluted)
21.81M 19.56M 18.46M 18.16M 15.56M
Currency in EUR

OSE Immunotherapeutics SA Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis